Research Center Profile:
FXM Research Corporation
We are a privately owned clinical research site that conducts
phase II, III, and IV clinical research trials specializing in
Dermatology. Our mission is to assist pharmaceutical companies and
CRO’s to successfully bring new studied medications to the
marketplace. This is achieved by providing the highest quality and
cost effective studies.
We are very confident that we can surpass other clinical
research sites on cost, speed and quality. We believe that our
input and findings will far exceed your expectations and that we
will be a valuable asset to any team.
We have acted as a clinical research site in numerous
dermatological studies where our normal enrollment consists of well
over 40 subjects with almost 99% compliance from such subjects.
We have extensive experience with the following therapeutic
areas:
|
|
|
|
|
|
|
- Secondarily Infected Lesions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The average turnover time for regulatory documentation is
approximately 24 to 48 hours depending on the study and the
requirements therein.
Our principal investigator, Hector Wiltz, M.D.,
C.C.T.I., is on site full time. This is because our office
houses both; our research site and Dr. Wiltz’ private practice.
Our site includes a designated research area with private
examining rooms to provide confidentiality and comfort for our
subjects. Furthermore, our facility also includes a secured area
for studied medications, case report forms and record storage. A
private office is also available to ensure comfortable, peaceful
and undistracted monitoring visits for our CRA’s.
Our clinical research center is located inside the
Kendall Medical Center, which is on the corner of
Bird Road (SW 40th Street) and 117th Avenue with the Florida
Turnpike running parallel to the center. The Florida Turnpike South
can be accessed from either I-95, I- 595, I -75 or the 836 West.
The center can also be accessed from the Palmetto Expressway (826
North or South) by exiting on Bird Road and heading West just past
117th avenue.
Hector Wiltz, M.D., C.C.T.I
Principal Investigator
Dr. Wiltz is a board certified Dermatologist with over 18 years of
extensive experience. Furthermore, Dr. Wiltz has acted as Principal
Investigator on over 50 successful trials. In November of 2002, Dr.
Wiltz obtained his C.C.T.I. certification.
Francisco Moncada, R.N., B.S.N., C.C.R.C.
President & Director of Clinical
Research
Mr. Moncada has worked with Dr. Wiltz for over 12 years and has
extensive experience in dermatological disorders. As director, Mr.
Moncada handles all clinical and regulatory aspects involved in the
trials, oversees all personnel assisting in the trials, and
supervises subject conduct during the trial.
Antonio Jimenez, COO.
Maritza Blandon, CFO.
Edmar Jimenez, Administrative Service Analyst.
Lourdes Serrano, Senior Lead CCRC.
Melvin Lima, CRC.
Maria Ambros, RMA, CRC.
Paulina Torres, CMA, CRC.
Alejandra Mangual, Executive Secretary.
Maritza D. Blandon, Executive Secretary.
We are always ranked among the highest enrolling sites in trials
we participate in. This is because of our extensive patient/subject
database. Our patient/subject database consists of all patients
treated in Dr. Wiltz’ private practice, as well as, FXM’s own
subject database.
Our patient population consists of the following and includes
males and females of all age groups:
Our subjects participate in clinical trials for various reasons:
to help in the development of new medical therapies that may offer
better treatment or even cures for chronic diseases, to get medical
care, or in hopes of trying the latest treatment for a particular
disease or condition without having to worry about costly
visits.
For all regulatory issues we adhere to the assigned Central
Institutional Review Board.
Francisco Moncada, R.N., B.S.N., C.C.R.C
Director of Clinical Research
FXM Research Corporation
11760 Bird Road, Suite 452
Miami, FL 33175
USA
Phone: 305-220-5222
Fax: 305-220-5779
EMail: info@fxmresearch.com
If you are interested in contacting this center to discuss placing a clinical
trial there, please complete and send the E-mail form below. A representative from
the research center will then follow up with you.